The Department of Health currently stockpiles the first line treatment regimen (Tenofovir/metrictabine/efavirenze) which 90% of patients are prescribed on. There is adequate supplies of the first line treatment , 10 million units currently with no shortage of API at this time. The stockpile will last for eight (8) weeks.
END.